A comparosion between Chitrakaadi Vati and Panchkolsidhha Peya in malabsorption.

Phase 1/2

Not yet recruiting

• Conditions: Diseases of the digestive system. Ayurveda Condition: GRAHANIDOSHAH, (2) ICD-10 Condition: K582||Mixed irritable bowel syndrome. Ayurveda Condition: GRAHANIDOSHAH,

• Registration Number: CTRI/2025/06/089356
• Lead Sponsor: SGT University Gurugram Haryana

Brief Summary

*Grahani Roga* is a disease thataffects the *Annavaha* and *Purishavaha Srotasa* and is closelyrelated to the imbalance of *Agni* and the formation of *Ama*.

Ayurveda emphasizes the role of **Agni** inmaintaining overall health. Disruptions in Agni are believed to be central tothe development of Grahani Rog. Both drugs’ ingredients are known to stimulatedigestive fire and improve the function of the gastrointestinal tract. Byfocusing on how Panchkol Peya and Chitrakaadi Gutika works at a physiologicallevel, the research can contribute to a better understanding of its role inrestoring **Agni** and improving digestive health.

§  One trial group will be given Erand Bhrishta Haritakifor Koshtha Shudhhi continuously for 5 days followed by administration ofPanchkol Peya daily for 4 weeks during lunch and another control group will be similarlygiven EBH for Koshtha Shudhhi followed by Chitrakadi Gutika for the sameduration and results will be compared.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2025-06-19
• Study Start: 2025-06-30

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Patients within the mentioned age group who have visible symptoms of Grahani will be taken for study.

Exclusion Criteria

Pregnancy, Lactation or any other serious systemic ailment, other gastrointestinal diseases Atisara, Gulma, Pravahika.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate efficacy of Panchkol Peya in the management of Grahani Roga in comparision to Chitrakadi Gutika, already proven drug.	After 15 days.

Secondary Outcome Measures

Name	Time	Method
To evaluate the reduction in symptoms like bloating, indigestion, & irregular bowel movements	To study the reduction in Ama formation in individuals with Grahani Roga

Trial Locations

Locations (1)

SGT University, Gurugram, Haryana; 🇮🇳 Gurgaon, HARYANA, India

SGT University, Gurugram, Haryana

🇮🇳Gurgaon, HARYANA, India

DrSwati Sharma

Principal investigator

08168175876

dr.swati158@gmail.com